US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Amgen (NQ:AMGN)

403.04 -4.23 (-1.04%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2 3 4 5 6 7 8 9
...
72 73 Next >
News headline image
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? ↗
Amgen trades at a cheaper valuation but carries higher leverage, while Vertex boasts pristine finances and 32% net margins, a classic trade-off between value and quality. 
Via The Motley Fool
News headline image
Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock. ↗
Lilly may be impacted by Novartis' pelacarsen flop -- but not by much. 
Via The Motley Fool
News headline image
SCHD's Stunning Reversal: Schwab's Flagship Dividend ETF Is Up 29% and Climbing ↗
Given what's going on in the world and in the market, perhaps it's natural that SCHD is surging. 
Via The Motley Fool
Topics Artificial Intelligence ETFs World Trade
Friday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
News headline image
Amgen Highlights 26% Growth Drivers, IMDELLTRA Momentum and MariTide Potential ↗
Amgen (NASDAQ:AMGN) executives highlighted growth across its key commercial products, progress in late-stage development programs and a continued focus on profitability and cash returns during a Wells... 
Via MarketBeat
Topics ETFs
These dow jones stocks are moving in today's session ↗
Via Chartmill
News headline image
Amgen Drops 10% on a Trial It Didn't Even Run ↗
AMGN stock fell after Novartis' Pelacarsen trial failed, though Amgen's own Olpasiran and Repatha differ in mechanism and results, and analysts have kept price targets largely intact. 
Via MarketBeat
News headline image
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026? ↗
Amgen is profitable and paying a growing dividend, while Revolution Medicines is burning cash to fund what could be one of the most important cancer drug launches in years. 
Via The Motley Fool
News headline image
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
One company is generating billions in revenue and raising its dividend. The other is burning cash in pursuit of a scientific breakthrough that could change how diseases are treated. 
Via The Motley Fool
Which dow jones stocks are moving on Thursday? ↗
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026? ↗
Amgen trades at a fraction of Moderna's valuation, but one company is burning cash while the other generates billions, a critical divide for income-focused investors. 
Via The Motley Fool
Stay informed with the top movers within the dow jones index on Wednesday. ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Tuesday. ↗
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
What's going on in today's session: dow jones movers ↗
Via Chartmill
These S&P500 stocks are moving in today's session ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case. ↗
Investors always need to appreciate risk before buying into any clinical-stage biopharmaceutical company. 
Via The Motley Fool
News headline image
Revolution Medicines Got Its Breakthrough—What Moves It Next? ↗
FDA approved Revolution Medicines' RASONQUE for pancreatic cancer, but RVMD stock stayed flat as investors had priced in the news early, with rising expenses now in focus. 
Via MarketBeat
Which dow jones stocks are moving on Friday? ↗
Via Chartmill
News headline image
1 Healthcare Stock for Long-Term Investors and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be... 
Via StockStory
News headline image
If the AI Boom Slows Down, History Says This Is the Smartest Way to Protect Your Long-Term Portfolio ↗
The Schwab US Dividend Equity ETF is a safe all-weather investment. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
Which dow jones stocks are moving on Wednesday? ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Tuesday. ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
News headline image
Just Starting Out With $5,000? 3 Magnificent ETFs to Buy in 2026. ↗
These 3 ETFs would give you a strong long-term portfolio to build from. 
Via The Motley Fool
Topics ETFs
News headline image
Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
72 73 Next >